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Objective: To determine whether unihemispheral hemodynamic failure is independently associ-
ated with cognitive impairment among participants in the National Institute of Neurological Disor-
ders and Stroke–sponsored, multicenter, randomized clinical trial, Randomized Evaluation of
Carotid Occlusion and Neurocognition (RECON).
Methods: Forty-three patients were randomized into RECON after recent symptomatic carotid artery
occlusion and asymmetrically increased oxygen extraction fraction (OEF) by PET (OEF ratio 1.13),
indicating stage II hemodynamic failure on the side of occlusion. The PET-positive patients were com-
pared with 28 RECON-enrolled patients who met all clinical and radiographic inclusion/exclusion cri-
teria but had no OEF asymmetry. A multivariable regression compared patients with PET OEF 1.13
or 1.13, stratifying by TIA vs stroke as the qualifying event. The dependent variable was a compos-
ite neurocognitive score derived from averaging age-normalized z scores on a test battery that in-
cluded global and internal carotid artery (ICA) side-relevant hemisphere-specific tests.
Results: There were no differences in demographic, clinical, or radiologic characteristics between
the PET-positive and PET-negative patients except for PET OEF asymmetry. The unadjusted
average neurocognitive z score was 1.45 for the PET-positive and 1.25 for the PET-negative
patients, indicating cognitive impairment in both groups but no difference between them (p 
0.641). After adjustment for age, education, side of occlusion, depression, and previous stroke,
there was a significant difference between PET-positive and PET-negative patients among those
with TIA as a qualifying event (average z score  1.41 vs 0.76, p  0.040). Older age and
right ICA side were also significant in this model.
Conclusion: Hemodynamic failure is independently associated with cognitive impairment in pa-
tients with carotid occlusion. This finding establishes the physiologic parameter upon which the
extracranial-intracranial bypass will be tested. Neurology® 2012;78:250–255
GLOSSARY
CBF  cerebral blood flow; COSS  Carotid Occlusion Surgery Study; CVR  cerebrovascular resistance; EC-IC  extracranial-
intracranial; ICA  internal carotid artery; OEF  oxygen extraction fraction; RECON  Randomized Evaluation of Carotid Occlu-
sion and Neurocognition.
Carotid artery disease has been associated with cognitive impairment,1-4 but correlations with
quantitative measures of cerebral blood flow (CBF) have been rare. The Randomized Evalua-
tion of Carotid Occlusion and Neurocognition (RECON) is an National Institute of Neuro-
logical Disorders and Stroke–sponsored, multicenter, randomized, controlled clinical trial that
is an ancillary study of the Carotid Occlusion Surgery Study (COSS). RECON was designed to
test the hypothesis that surgical anastomosis of the extracranial superficial temporal artery to
the intracranial middle cerebral artery (EC-IC bypass) when added to best medical therapy, can
improve or preserve cognitive function at 2 years in patients with symptomatic internal carotid
artery (ICA) occlusion and stage II hemodynamic failure better than the best medical therapy
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alone. The parent study, COSS, tested the hy-
pothesis that EC-IC bypass would signifi-
cantly reduce the risk of subsequent stroke.5
Both COSS and RECON assessed hemi-
spheral hemodynamic failure by identifying
increased oxygen extraction fraction (OEF)
by PET on the side of occlusion.
Reported here are the results of the baseline
cognitive testing of the RECON cohort, com-
paring cognitive function in those who had
unihemispheral cerebral hypoperfusion with a
control group of clinically identical patients
with carotid occlusion but without increased
OEF. We took advantage of the 2-step ran-
domization process in the study design to in-
clude this subgroup of enrolled but not
randomized patients to serve as controls. Our
data represent an advance over previous stud-
ies in obtaining quantitative blood flow data,
measuring cognitive impairment with a
disease-specific cognitive battery, and using
an appropriately matched control group.
METHODS Subjects. Patients who met the inclusion criteria
of symptomatic carotid artery occlusion (hemispheral TIA or minor
stroke) 120 days before enrollment were enrolled into RECON
between 2004 and 2009. Symptoms had to have been attributable
to the carotid occlusion, and patients had to have a Barthel Index
12/20 at the time of enrollment. Nonatherosclerotic causes of
carotid occlusion were excluded based on all available clinical data.
TIA was defined clinically as having no residual deficit after 24
hours. MRI was not available in all patients and so was not used in
the definition of TIA. All enrolled patients underwent a PET scan to
measure OEF. Status of collateral arteries was not assessed as part of
the protocol. Patients were eligible for randomization to one of the
treatment arms if they had asymmetrically increased OEF by PET
(OEF ratio 1.13), indicating stage II hemodynamic failure on the
side of occlusion. Those who had an OEF ratio 1.13 were not
randomized and went no further in the study but were included in
the current analysis as control subjects. The PET threshold of 1.13
was determined by a prospective natural history study, the St. Louis
Carotid Occlusion Study, which examined thresholds of OEF asso-
ciated with a higher rate of subsequent stroke.6 Details of the PET
protocol are published elsewhere.5 Additional exclusion criteria for
the RECON study were prior clinical diagnosis of dementia due to
any cause, education level less than grade 4, or any neurologic deficit
that prevented acquisition of informed consent. Thus, the study
group includes no subjects who would be more impaired than a
level equivalent to mild cognitive impairment, and some might be
normal. The PET-positive patients were compared with the 28
RECON-enrolled patients who met all clinical and radiographic
inclusion and exclusion criteria but were not randomized because
they had no OEF asymmetry (PET-negative patients).
Standard protocol approvals, registrations, and patient
consents. All patients provided informed consent. The study was
approved by the Columbia University Institutional Review Board.
Neurocognitive testing. Patients underwent a 1-hour neuro-
cognitive battery consisting of 14 standardized neuropsychologi-
cal tests, administered by a neuropsychologist or trained
technician. The battery was designed to assess left hemisphere
function, right hemisphere function, and global function. All
tests had published, age-adjusted norms.7-16 All patients were ad-
ministered all 14 neurocognitive tests. The order of test adminis-
tration remained constant, accommodating the delays required
for recall intervals and minimizing stimulus interference in
memory tasks. The test battery is summarized in table 1.
Because hemodynamic failure in the hemisphere ipsilateral
to the symptomatic carotid occlusion was hypothesized to affect
predominantly functions associated with that hemisphere, as
well as global cognitive function that would also use that hemi-
sphere, composite scores were generated for each patient based
on the hemisphere of interest: We first transformed the raw test
scores for each patient into test-specific z scores for each test in
the battery, derived from published norms. We then calculated a
composite z score based on the average z score for the appropri-
ate set of tests for each patient (sum of the relevant z scores
divided by the number of tests included). For patients with left
carotid occlusion, left hemisphere and global test scores were
used; for patients with right carotid occlusion, right hemisphere
and global test scores were used.
Statistical analysis. A multivariable regression was performed
comparing patients with a PET OEF ratio 1.13 with those
with an OEF ratio 1.13, stratifying by TIA vs stroke as the
qualifying event. This preplanned analysis was formulated to en-
able us to focus on the patients with TIA, a group in which the
likely cognitive effects of stroke, per se, would not confound the
hypothesized effects of hypoperfusion. Thus, for this baseline
study we postulated that any potential hypoperfusion-
attributable effects on cognition would be seen best in those who
qualified for the study (PET-positive) with TIA only. Our de-
pendent variable was the composite neurocognitive z score,
which was the only outcome measure of cognitive function in






Trail Making Part A Global
Trail Making Part B Global
Digit Span Global
Digit Symbol Global







Word Fluency (Controlled Oral
Word Association)
Left
Rey Figure (copy) Right
Rey Figure (delayed recall) Right
Line Bisection Right
Target Cancellation Right
Grooved Pegboard (affected hand) Left/right
Grooved Pegboard (unaffected hand) Global
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the study. The main independent variable was PET OEF, di-
chotomized to 1.13 vs 1.13. Age, gender, education level
(8th grade, 9th–12th grade [high school], or 13 years [some
college]) were entered into the model as covariates, along with
ICA side, depression (as measured by the Center for Epidemio-
logic Studies–Depression scale, and previous stroke. Patients
missing any of these data elements were eliminated from the
analysis.
RESULTS A total of 71 patients, 32 with TIA as the
qualifying event and 39 qualifying with mild to
moderate stroke, met the enrollment criteria for this
study and had complete data. There were no differ-
ences in demographic, clinical, or radiologic charac-
teristics between the PET-positive (OEF ratio
1.13) and PET-negative (OEF ratio 1.13) pa-
tients, except for PET OEF asymmetry and previous
stroke (table 2). The unadjusted average neurocogni-
tive z score was 1.45 below the normative mean for
the PET-positive and 1.25 for the PET-negative
patients, indicating cognitive impairment among
both groups (with and without hemodynamic fail-
ure) but no significant difference between them (p 
0.641).
In the multivariable regression analysis, after ad-
justment for age, education, side of occlusion, and
previous stroke, there was a significant difference be-
tween PET-positive and PET-negative patients
among those with TIA as a qualifying event (average
z score  1.41 vs 0.76, p  0.040). Older age
and right ICA side were also significant in this
model, as shown in table 3.
DISCUSSION We show in a hemodynamically
well-characterized cohort that cognitive impairment
was independently associated with unilateral cerebral
hypoperfusion in patients with carotid artery occlu-
sive disease. Specifically, stage II hemodynamic fail-
ure, as measured by increased OEF on the side of
carotid occlusion, was associated with cognitive dys-
function. By taking advantage of the 2-step enroll-
ment in the COSS/RECON study design, we were
able to establish a well-matched control group: those
who met the clinical inclusion criteria of symptom-
atic carotid artery occlusion but who differed only by
the physiologic parameter of a lack of hemodynamic
failure in the hemisphere supplied by the occluded
carotid artery. Additional specificity for the indepen-
dent effect of the hypoperfusion was afforded by the
use of a cognitive battery that emphasized the hemi-
sphere of interest and by our stratification by clinical
subtype to focus on the subset of patients who quali-
fied for the study without having new infarction or
lasting clinical deficit (patients with TIA). In show-
ing the association between cognitive dysfunction
and hemodynamic failure in those with an absence of
imaging-verified ischemic damage at the time of
baseline cognitive testing, we could be more confi-
dent that the cognitive effects were attributable to the
hemodynamic failure. The presence of age in the
model suggests that the impact of hypoperfusion on
cognition was greater with increasing age.
Demonstration of a clear correlation between ce-
rebral hypoperfusion and cognitive impairment in
the setting of carotid artery disease has been elusive,
in part because those with carotid artery disease share
vascular risk factors with patients who have no large
vessel disease.17,18 Both sets of patients may have mi-
croinfarcts and other ischemic lesions, which are as-
sociated with cognitive decline.18-21 Several case series
have shown cognitive dysfunction in patients with
carotid artery stenosis or occlusion22-24 and even
showed reversibility of cognitive impairment with
Table 2 Basic descriptive statistics for variables of interest, stratified by




(n  28) p Value
Age
Mean (SD) 56.98 (1.43) 58.50 (1.64) 0.4938
Median (IQR) 57.00 (15.00) 57.50 (11.50) 0.5208
Gender, n (%)
Male 29 (67.44) 20 (71.43) 0.7226
Female 14 (32.56) 8 (28.57)
Handedness, n (%)
Left 4 (9.3) 3 (10.71)
Right 39 (90.7) 25 (89.29) 0.8454
Education, n (%)
<8th grade 2 (4.65) 1 (3.57)
High school 26 (60.47) 13 (46.43) 0.4485
College 15 (34.88) 14 (50)
Side of ICA occlusion, n (%)
Left 22 (51.16) 14 (50)
Right 21 (48.84) 14 (50) 0.9237
Event type, n (%)
TIA 20 (46.51) 12 (42.86)
Stroke 23 (53.49) 16 (57.14) 0.7623
Ipsilateral/contralateral OEF ratio
Mean (SD) 1.25 (0.03) 1.05 (0.01) 0.0001
Median (IQR) 1.18 (0.15) 1.05 (0.07) 0.0001
Previous stroke, n (%)
No 22 (51.16) 22 (78.57)
Yes 21 (48.84) 6 (21.43) 0.0201
CES-D scale
Mean (SD) 18.17 (1.66) 17.19 (2.38) 0.7295
Median (IQR) 16 (15) 15 (11) 0.6020
Abbreviations: CES-D  Center for Epidemiological Studies–Depression; ICA  internal ca-
rotid artery; IQR  interquartile range; OEF  oxygen extraction fraction.
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revascularization,2-4 but an independent association
with hypoperfusion has been difficult to establish.
With the refinement of PET and other hemody-
namic techniques in the 1980s, it became possible to
quantify cerebral hemodynamics in terms of CBF,
oxygen and glucose utilization, and cerebral autoreg-
ulatory capacity.25-27 In addition, unlike methods
that measured CBF alone, the PET method allowed
functionally important hypoperfusion resulting from
carotid occlusive disease to be distinguished from hy-
poperfusion due simply to reduced metabolic de-
mands of damaged (infarcted) tissue. Using
quantitative PET methods, we were able to define
more precisely cerebral hemodynamic status. Cur-
rent hemodynamic theory holds that as perfusion
pressure falls, CBF is maintained by autoregulatory
vasodilation of cerebral arterioles. As perfusion pres-
sure falls further, CBF begins to decrease and a met-
abolic compensation occurs as the OEF increases to
maintain tissue oxygen metabolism. This stage II he-
modynamic failure, sometimes referred to as misery
perfusion,28 is thought to represent a vulnerable he-
modynamic state in which any further drop in perfu-
sion will produce ischemia. Reduced cerebrovascular
resistance (CVR) on the side of carotid occlusion or
stenosis indicates preexisting autoregulatory vasodila-
tion and has been associated with cognitive impair-
ment in patients with asymptomatic carotid stenosis
at baseline29 and with cognitive improvement when
the impaired CVR is reversed after endarterectomy.30
Other studies have shown a lack of association be-
tween CVR and cognitive impairment.31
In an important single case study, cerebral hemo-
dynamic measures were assessed in a 55-year-old
man with bilateral ICA occlusions presenting with
subacute onset of severe behavioral and cognitive
changes.32 Quantitative CBF and PET studies
showed a 40%–50% reduction in blood flow and
metabolism. After EC-IC bypass, there were signifi-
cant increases in CBF and metabolism, accompanied
by neuropsychological improvement. In a larger case
series, among 25 patients with mild stroke or TIA,
unilateral ICA or middle cerebral artery occlusion,
and increased OEF by PET, verbal and performance
IQ and full-scale IQ scores were all impaired before
EC-IC bypass. After intervention, there was a signif-
icant increase in IQ scores that was correlated in a
multivariable analysis with measures of CBF and
metabolism.33
The current study supports a mechanistic basis
for what has been reported mostly as observational
cases and clinical case series. The notion that reduc-
tion of CBF in a hemisphere fed by an occluded ca-
rotid artery is sufficient to produce significant
cognitive dysfunction in the absence of acute infarc-
tion has until now been inadequately demonstrated.
One limitation in our study is that we did not have
imaging results for all our patients to know whether
the topography and distribution of preexisting isch-
emic changes were different between those with nor-
mal vs abnormal OEF. Although increased OEF was
shown to be independently associated with cognitive
impairment in this study, it could be that previous
strokes, which did not differ categorically between
those with and without increased OEF, had different
distributions or morphologies that could account for
differences in cognitive function.34,35 In addition, in-
creased OEF can cause unihemispheric neuronal loss
without infarction,36 which could explain our data as
well. If either differences in previous stroke topogra-
phy or differences in selective neuronal loss were
present in our cohort, then improvement in OEF
might not result in improved cognition. The ques-
tion of whether cognitive dysfunction is reversible
when the hemodynamic impairment is treated will
need to await the main results of the RECON trial.
Nonetheless, by investigating the association be-
tween cerebral hemodynamic failure and cognitive
impairment using reliable, quantitative methods for
physiologic and behavioral measurements and com-
paring with an appropriate control group, we have
been able to show the hemodynamic effects of the
carotid occlusive disease on cognition, thus establish-
ing the substrate upon which a treatment, in this case
EC-IC bypass, may be meaningfully tested.
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